1887

oa Southern African Journal of Anaesthesia and Analgesia - Incretion therapy 2011 : hype or reality? : refresher course

 

Abstract

Type 2 diabetes has assumed a pandemic prevalence. In the absence of metabolic control, life expectancy in patients with diabetes is reduced by a mean of 15 years, and morbidity in relation to vascular and neuropathic complications, some three- to fourfold. Adequate metabolic control remains elusive and worldwide, fewer than 40% of patients with diabetes achieve glycaemic targets. This poor outcome is attributable in part to the suboptimal, non-physiological glucose-lowering therapies that are currently available and in routine use. More specifically, effective glucose lowering is currently limited by the concurrent adversities of hypoglycaemia and weight gain.

Loading

Article metrics loading...

/content/medsajaa/17/1/EJC73847
2011-01-01
2016-12-05
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error